Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
about
The breast cancer epidemic: 10 factsPrevention of Ovarian Hyperstimulation Syndrome: A ReviewEstrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysisGnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review articleNatural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practiceGnRH agonist for triggering of final oocyte maturation: time for a change of practice?Macrophages regulate corpus luteum development during embryo implantation in mice.GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysisAssessment of the luteal phase in stimulated and substituted cycles.Luteal Phase Support in the Intrauterine Insemination (IUI) Cycles: A Randomized Double Blind, Placebo Controlled StudyEffect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial.Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study.Addition of gonadotropin releasing hormone agonist for luteal phase support in in-vitro fertilization: an analysis of 2739 cycles.Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles.Has ART Finally Got a Patient-Friendly Progesterone?Emerging drugs in assisted reproduction.Effect of luteal-phase support on endometrial microRNA expression following controlled ovarian stimulation.Subclinical pregnancy losses among women undergoing in-vitro fertilization with ICSI.Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice.Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcomeEndometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis.An update of luteal phase support in stimulated IVF cycles.Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonistEvaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: A prospective randomized study.Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.Follicular determinants of pregnancy establishment and maintenance.Use of progestogens in pregnant and infertile patients.Effects of maternal environment during gestation on ovarian folliculogenesis and consequences for fertility in bovine offspring.Clinical use of progesterone in infertility and assisted reproduction.Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT.Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization.Evidence that high variation in ovarian reserves of healthy young adults has a negative impact on the corpus luteum and endometrium during estrous cycles in cattle.Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study.Luteal phase support in in vitro fertilization: meta-analysis of randomized trials.A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of <or=7 mm on day of egg retrieval.Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
P2860
Q22299214-BB044A3A-F42E-4050-B312-D118DEDF2B86Q26828442-F3A4E072-0DF3-4888-A75B-E9D90CC632CFQ26849816-09912B0E-9510-422F-851C-3E487304DB4BQ28077044-A8409FD8-B01E-4F0C-AD61-53EA0D2A0C6FQ28269584-2D91EC1A-F1C7-45FC-B1B9-1C0FAA8A7954Q28308094-CBB5D11E-592A-46F4-9BA9-EAEAF23D1429Q30541876-94134A4C-B65A-4722-AFB1-50B4B544F755Q33226124-7458C8AD-AABA-48B2-B603-2D7B6B70FE10Q33809795-B5CC8068-4223-424D-A467-287446ABE961Q34142490-E8EB9B2D-59AA-48A5-8AE9-65BA90BA064FQ34608208-0C6E90AF-8968-41D4-B55E-E4EE2F34090BQ34705558-9BFC3DB3-C355-4D16-8162-E7F40352DA43Q35276503-7CB910EA-CE1C-4BBB-B8A9-4BB143FA5780Q35471131-E0AC6E8C-5072-4FF5-AD3B-EC576823C290Q35674020-CC1D1756-3377-491F-A34C-5BC1EBCA078CQ35686985-8BA6A571-B48A-4EF8-8448-EA794AB60E1CQ35765876-D37D9FD5-B7F1-4A50-8D49-DA6CABA0C067Q36083776-944ECEB3-91D8-4FAE-BE34-6B14CB6C30DEQ36150659-CFBBFC16-A12A-40CA-AF8A-C2D2A07075DBQ36290928-F24DB3D9-105E-4764-AE24-F1FCDC08451BQ36423241-A3A30884-482E-4070-934A-7E63202E46ABQ36532510-67C40412-F21B-43DD-9463-D451FBB22A83Q36706504-835608B5-2050-456A-AC0C-0A936619323BQ36742625-0E4B599B-24F9-41B8-BBDB-F2434853FE38Q36878307-76319B9D-E12C-44D9-9E3A-8D42C151F53CQ36970222-90FCF309-EA8A-4C33-BC23-1363D3B2087DQ37024897-52C37EFD-8351-4DFA-ABC3-C44E68CDEE8CQ37615489-86B6BD53-FEAE-4B97-8DBC-820B6B0AE297Q37994630-5E94176C-A302-4499-84A3-7EDE596B2BB2Q38006373-42B4C163-0343-466D-9D46-4D196DA26A74Q38029018-8FCA190F-E50B-423E-AE11-F77190BC2BA7Q38582186-BF3A4913-940D-430A-A2E6-50355FE66E8BQ40320672-5D0F6FCA-B977-4BF7-B664-E0CB02B2B3EAQ41977622-64206A23-84BB-4E18-BB33-1B084B5A2F45Q42449251-806920A8-3B61-457C-8F6A-F9C6B36158B0Q45182698-8ABBA3C3-25DB-4EB3-A882-EE103EA80BA0Q46398886-E06EC0B4-62C3-46E7-9F85-FF57B9DDA91BQ46568123-E7962E83-90F6-4050-B25D-2D4D86B826E1Q46718453-103655F4-B5BC-4A17-817B-79575ADDC77CQ46864624-B2DBDC9F-2166-45F4-97F7-809FD67721D1
P2860
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@ast
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@en
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@nl
type
label
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@ast
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@en
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@nl
prefLabel
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@ast
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@en
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@nl
P356
P1433
P1476
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials.
@en
P2093
P304
P356
10.1093/HUMREP/17.9.2287
P407
P577
2002-09-01T00:00:00Z